SOAGY vs. NVO

Last updated Jun 4, 2026

SOAGY (Sartorius Aktiengesellschaft) and NVO (Novo Nordisk A/S) are both stocks. Both are in the Healthcare sector — SOAGY in Medical Instruments & Supplies, NVO in Drug Manufacturers - General. Over the past 5 years, SOAGY returned -5.95%/yr vs 2.89%/yr for NVO. At a 0.10 correlation, their price movements are largely independent.

Performance

SOAGY vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sartorius Aktiengesellschaft (SOAGY) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SOAGY achieves a -1.55% return, which is significantly higher than NVO's -14.57% return.

SOAGY

• 1D: 0.21%
• 1M: 12.59%
• YTD: -1.55%
• 6M: -5.46%
• 1Y: 21.74%
• 3Y*: -6.95%
• 5Y*: -5.95%
• 10Y*: —

NVO

• 1D: -2.14%
• 1M: -5.38%
• YTD: -14.57%
• 6M: -8.62%
• 1Y: -38.01%
• 3Y*: -16.72%
• 5Y*: 2.89%
• 10Y*: 6.21%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SOAGY vs. NVO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
SOAGY Sartorius Aktiengesellschaft	-1.55%	30.06%	-39.37%	-6.83%	-37.01%	61.68%	-13.82%
NVO Novo Nordisk A/S	-14.57%	-39.22%	-15.93%	54.84%	22.66%	63.52%	-4.55%

Correlation

The correlation between SOAGY and NVO is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.24
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.10
Correlation (All Time) Calculated using the full available price history since Oct 14, 2020	0.10

The correlation between SOAGY and NVO shifts across timeframes, from 0.10 (all time) to 0.24 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap SOAGY : $19.67B NVO : $186.85B
EPS SOAGY : $0.47 NVO : $27.42
PE Ratio SOAGY : 120.53 NVO : 1.53
PEG Ratio SOAGY : 8.73 NVO : 0.07
PS Ratio SOAGY : 5.53 NVO : 0.57
PB Ratio SOAGY : 7.21 NVO : 0.92
Total Revenue (TTM) SOAGY : $3.56B NVO : $327.80B
Gross Profit (TTM) SOAGY : $1.62B NVO : $268.30B
EBITDA (TTM) SOAGY : $998.48M NVO : $181.54B

Return for Risk

SOAGY vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SOAGY

SOAGY Risk / Return Rank: 58
SOAGY Sharpe Ratio Rank: 60
SOAGY Sortino Ratio Rank: 56
SOAGY Omega Ratio Rank: 53
SOAGY Calmar Ratio Rank: 60
SOAGY Martin Ratio Rank: 59

NVO

NVO Risk / Return Rank: 14
NVO Sharpe Ratio Rank: 10
NVO Sortino Ratio Rank: 13
NVO Omega Ratio Rank: 12
NVO Calmar Ratio Rank: 15
NVO Martin Ratio Rank: 19

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SOAGY vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sartorius Aktiengesellschaft (SOAGY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SOAGY	NVO	Difference
Sharpe ratio: Return per unit of total volatility	0.54	-0.74	+1.28
Sortino ratio: Return per unit of downside risk	1.08	-0.83	+1.91
Omega ratio: Gain probability vs. loss probability	1.12	0.88	+0.24
Calmar ratio: Return relative to maximum drawdown	0.92	-0.69	+1.61
Martin ratio: Return relative to average drawdown	1.86	-1.03	+2.89
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SOAGY vs. NVO - Sharpe Ratio Comparison

The current SOAGY Sharpe Ratio is 0.54, which is higher than the NVO Sharpe Ratio of -0.74. The chart below compares the historical Sharpe Ratios of SOAGY and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	SOAGY	NVO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.54	-0.74	+1.28
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.11	0.08	-0.19
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.19	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.16	0.47	-0.63

Drawdowns

SOAGY vs. NVO - Drawdown Comparison

The maximum SOAGY drawdown since its inception was -69.53%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for SOAGY and NVO.

Drawdown Indicators

	SOAGY	NVO	Difference
Max Drawdown Largest peak-to-trough decline	-69.53%	-74.70%	+5.17%
Max Drawdown (1Y) Largest decline over 1 year	-23.78%	-55.03%	+31.25%
Max Drawdown (3Y) Largest decline over 3 years	-53.66%	-74.70%	+21.04%
Max Drawdown (5Y) Largest decline over 5 years	-69.53%	-74.70%	+5.17%
Max Drawdown (10Y) Largest decline over 10 years	—	-74.70%	—
Current Drawdown Current decline from peak	-55.14%	-69.48%	+14.34%
Average Drawdown Average peak-to-trough decline	-39.40%	-17.76%	-21.64%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.74%	36.88%	-25.14%

Volatility

SOAGY vs. NVO - Volatility Comparison

Sartorius Aktiengesellschaft (SOAGY) has a higher volatility of 11.65% compared to Novo Nordisk A/S (NVO) at 7.84%. This indicates that SOAGY's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SOAGY	NVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.65%	7.84%	+3.81%
Volatility (6M) Calculated over the trailing 6-month period	30.77%	37.83%	-7.06%
Volatility (1Y) Calculated over the trailing 1-year period	40.48%	51.76%	-11.28%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	52.50%	38.21%	+14.29%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	49.79%	32.49%	+17.30%

Dividends

SOAGY vs. NVO - Dividend Comparison

SOAGY's dividend yield for the trailing twelve months is around 0.31%, less than NVO's 4.29% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NVO Novo Nordisk A/S	4.29%	3.31%	1.68%	1.00%	1.20%	1.35%	1.87%	2.14%	1.45%	1.52%	2.87%	0.92%
SOAGY Sartorius Aktiengesellschaft	0.31%	0.26%	0.36%	0.42%	0.35%	0.07%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

SOAGY vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between Sartorius Aktiengesellschaft and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

SOAGY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sartorius Aktiengesellschaft reported a gross profit of 421.32M and revenue of 913.89M. Therefore, the gross margin over that period was 46.1%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

SOAGY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sartorius Aktiengesellschaft reported an operating income of 153.48M and revenue of 913.89M, resulting in an operating margin of 16.8%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

SOAGY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sartorius Aktiengesellschaft reported a net income of 57.12M and revenue of 913.89M, resulting in a net margin of 6.3%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.

Frequently Asked Questions

Can I hold both SOAGY and NVO in my portfolio?

SOAGY and NVO have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SOAGY or NVO?

SOAGY has higher volatility (11.65%) compared to NVO (7.84%). In terms of maximum drawdown, SOAGY dropped -69.53% vs NVO's -74.70%.

Which has better risk-adjusted returns?

SOAGY currently has the higher Sharpe Ratio (0.54 vs -0.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.